0 (0%) | 04-19 00:52 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 2.37 | 1-year : | 2.56 |
Resists | First : | 2.03 | Second : | 2.2 |
Pivot price | 1.96 | |||
Supports | First : | 1.75 | Second : | 1.46 |
MAs | MA(5) : | 1.84 | MA(20) : | 1.99 |
MA(100) : | 2.14 | MA(250) : | 2.65 | |
MACD | MACD : | -0.1 | Signal : | -0.1 |
%K %D | K(14,3) : | 23.9 | D(3) : | 20.1 |
RSI | RSI(14): 34.8 | |||
52-week | High : | 4.09 | Low : | 1.52 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CNF ] has closed above bottom band by 22.0%. Bollinger Bands are 7.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 1.89 - 1.9 | 1.9 - 1.91 |
Low: | 1.81 - 1.82 | 1.82 - 1.83 |
Close: | 1.83 - 1.85 | 1.85 - 1.87 |
Fri, 16 Jun 2023
Highly efficient and wearable thermoelectric composites based on carbon nanotube film/polyaniline - ScienceDirect.com
Mon, 27 Feb 2023
Regeneration and functional recovery of the completely transected optic nerve in adult rats by CNTF-chitosan | Signal ... - Nature.com
Thu, 17 Nov 2022
Ciliary neurotrophic factor-mediated neuroprotection involves enhanced glycolysis and anabolism in degenerating ... - Nature.com
Wed, 18 May 2022
Ciliary neurotrophic factor is increased in the plasma of patients with obesity and its levels correlate with diabetes and ... - Nature.com
Tue, 19 May 2020
CNTF-STAT3-IL-6 Axis Mediates Neuroinflammatory Cascade across Schwann Cell-Neuron-Microglia - ScienceDirect.com
Fri, 27 Sep 2019
CNTF and Nrf2 Are Coordinately Involved in Regulating Self-Renewal and Differentiation of Neural Stem Cell during ... - ScienceDirect.com
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
Exchange:
|
|
Sector:
|
|
Industry:
|
|
Shares Out | 69 (M) |
Shares Float | 948 (M) |
Held by Insiders | 1.3 (%) |
Held by Institutions | 18.9 (%) |
Shares Short | 11 (K) |
Shares Short P.Month | 7 (K) |
EPS | 0.33 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 58.45 |
Profit Margin | 19.6 % |
Operating Margin | 2.7 % |
Return on Assets (ttm) | 1 % |
Return on Equity (ttm) | 4.1 % |
Qtrly Rev. Growth | 31.2 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 12.21 |
EBITDA (p.s.) | 0 |
Qtrly Earnings Growth | -45.8 % |
Operating Cash Flow | 0 (M) |
Levered Free Cash Flow | 0 (M) |
PE Ratio | 5.6 |
PEG Ratio | 0 |
Price to Book value | 0.03 |
Price to Sales | 0.15 |
Price to Cash Flow | 0 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |